Dr. Josh Lehrer

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get LSTA alerts

About Dr. Josh Lehrer

Dr. Josh Lehrer is recorded as COO at Lisata Therapeutics, Inc. (LSTA) since September 17, 2026. Lisata Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that Dr. Josh Lehrer was appointed Chief Operating Officer and President of Lisata Therapeutics and Chief Executive Officer of Marea. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown (Chairman) and 7 others.

“said Dr. Josh Lehrer, newly appointed Chief Operating Officer and President of Lisata Therapeutics and Chief Executive Officer of Marea.”

Lisata Therapeutics, Inc. Form 8-K, filed September 17, 2026 · Read the filing

Affiliation history

Lisata Therapeutics, Inc. (LSTA)
COO

SEC 8-K

Current
2026-09-17–present

Company network

Lisata Therapeutics, Inc.

LSTA

Current role

Biotechnology · Healthcare

COO

2026-09-17–present

Leadership on record at Lisata Therapeutics, Inc.

David J. Mazzo CEO, Board Member
David J. Mazzo, Ph.D. CEO
Gregory Brown Chairman
Gregory Brown, M.D. Chairman
Josh Lehrer COO
Josh Lehrer, M.D., M.Phil., FACC COO
Tariq Imam General Counsel
James Nisco Chief Accounting Officer
Anne Whitaker Board Member
CLASS I Board Member

Recent activity

Executive change Appointed: Chief Operating Officer and President of Lisata Therapeutics and Chief Executive Officer of Marea Lisata Therapeutics, Inc. (LSTA)
2026-09-17